A biotech company with a press conference scheduled for wednesday and a pps that has risen from a penny to a quarter and it should hit forty cents short term and two fifty long term.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.